Sintx Technologies, Inc.
SINT
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$2.55
FAIR PRICE
$1.53
MARGIN
$1.02
P/E Ratio
N/A
Div. Yield
N/A
ROE
-367.2%
Market Cap
$7M
Small-cap
COMING SOON
Get notified when SINT's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Kevin Trask
COUNTRY
US
HEADQUARTERS
Salt Lake City
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate SINT's fair price
Sintx Technologies, Inc.'s fair price of $1.53 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $2.55, SINT trades 40.0% above its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting SINT's risk profile.
RELATIVE · 30%
Comparing SINT's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for SINT, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for SINT.
Explore on BuliosFAQ
What is the fair price of SINT?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Sintx Technologies, Inc. is $1.53. At the current market price of $2.55, SINT trades 40.0% above its calculated fair value.
Is SINT overvalued or undervalued?+
Sintx Technologies, Inc. is currently overvalued based on our valuation model. The stock trades at $2.55, which is 40.0% above the fair price of $1.53.
How often is SINT's fair price updated?+
We update fair price calculations for SINT daily after market close. The current fair price of $1.53 incorporates the latest market data and sector multiples.
What factors affect SINT's fair price calculation?+
SINT's fair price of $1.53 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -367.2%.
Is SINT a good buy right now?+
At $2.55, SINT trades 40.0% above our fair value estimate of $1.53. The stock is currently overvalued. ROE stands at -367.2% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does SINT pay dividends?+
SINT does not currently pay a dividend.